(Q37414226)

20 August 2017

Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial (English)

1 reference

20 August 2017

1 reference

Michiel Thomeer

8

0 references

William MacNee

object named as

William MacNee

7

0 references

Ulrich Costabel

4

object named as

Ulrich Costabel

1 reference

20 August 2017

Jürgen Behr

1

1 reference

20 August 2017

Maurits Demedts

2

1 reference

20 August 2017

Roland Buhl

3

1 reference

20 August 2017

Richard P N Dekhuijzen

5

1 reference

20 August 2017

Henk M Jansen

6

1 reference

20 August 2017

Benoit Wallaert

9

1 reference

20 August 2017

Francois Laurent

10

1 reference

20 August 2017

Andrew G Nicholson

11

1 reference

20 August 2017

Eric K Verbeken

12

1 reference

20 August 2017

Johny Verschakelen

13

1 reference

20 August 2017

C D R Flower

14

1 reference

20 August 2017

Stefano Petruzzelli

15

1 reference

20 August 2017

Paul De Vuyst

16

1 reference

20 August 2017

J M M van den Bosch

17

1 reference

20 August 2017

Eulogio Rodriguez-Becerra

18

1 reference

20 August 2017

Ida Lankhorst

19

1 reference

20 August 2017

Marco Sardina

20

1 reference

20 August 2017

Gabrielle Boissard

21

1 reference

20 August 2017

IFIGENIA study group

22

1 reference

20 August 2017

27 October 2009

1 reference

20 August 2017

1 reference

20 August 2017

10

1 reference

20 August 2017

101

1 reference

https://scigraph.springernature.com/pub.10.1186/1465-9921-10-101

20 August 2017

0 references

cites work

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

High-dose acetylcysteine in idiopathic pulmonary fibrosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

The clinical course of patients with idiopathic pulmonary fibrosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

Antioxidant therapy for idiopathic pulmonary fibrosis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774307

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1465-9921-10-101

Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1465-9921-10-101

Pulmonary hypertension in interstitial lung disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1465-9921-10-101

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

21 January 2018

1 reference

12 December 2020

Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression

1 reference

12 December 2020

Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies

1 reference

12 December 2020

Idiopathic pulmonary fibrosis: predicting response to therapy and survival

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-10-101

1 reference

Dimensions Publication ID

20 August 2017

0 references

1 reference

20 August 2017

1 reference